Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions

Heart Failure With Preserved Ejection FractionDiabetes Mellitus, Type 2Ketonemia

Interventions

DIETARY_SUPPLEMENT

Ketone ester

Commercially available ketone supplement

DIETARY_SUPPLEMENT

Placebo drink

Isocaloric placebo

Trial Locations (1)

Aarhus University Hospital, Aarhus

All Listed Sponsors

lead

University of Aarhus

OTHER